Liver fat, visceral adiposity, and sleep disturbances contribute to the development of insulin resistance and glucose intolerance in nondiabetic dialysis patients

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 295, Issue 6, 2008, Pages

  Sakkas, Giorgos K ^a,b,d   Karatzaferi, Christina ^a,b   Zintzaras, Elias ^a   Giannaki, Christoforos D ^a,b   Liakopoulos, Vassilios ^a,c   Lavdas, Eleftherios ^a   Damani, Eleni ^a   Liakos, Nikos ^a   Fezoulidis, Ioannis ^a   Koutedakis, Yiannis ^a,b   Stefanidis, Ioannis ^a,c  

^a UNIVERSITY OF THESSALY   (Greece)

^b Institute for Human Performance and Rehabilitation   (Greece)

^c INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^d UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Functional capacity; Homeostasis assessment model of insulin resistance; Insulin sensitivity index by Matsuda; Oral glucose insulin sensitivity; Quality of life; Quantitative insulin sensitivity check index

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE TEST; FATTY LIVER; FEMALE; GLUCOSE INTOLERANCE; HEMODIALYSIS PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; TARGET ORGAN;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADOLESCENT; ADULT; AGED; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIVER; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; NUTRITIONAL STATUS; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SLEEP DISORDERS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 57749109021     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00935.2007     Document Type: Article

References (63)

1. Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev 8: 119-127, 2007.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28, Suppl 1: S37-S42, 2005.
3. Arsenault BJ, Lachance D, Lemieux I, Almeras N, Tremblay A, Bouchard C, Perusse L, Despres JP. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med 167: 1518-1525, 2007.
4. Azuma K, Heilbronn LK, Albu JB, Smith SR, Ravussin E, Kelley DE. Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 293: E435-E442, 2007.
5. Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, Sirard JR. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 298: 2296-2304, 2007.
6. Brouwer BG, Visseren FL, van der Graaf Y. The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study. Am Heart J 154: 1146-1152, 2007.
7. Cali AM, Zern TL, Taksali SE, de Oliveira AM, Dufour S, Otvos JD, Caprio S. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care 30: 3093-3098, 2007.
8. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4: 225-228, 2003.
9. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4: 1205-1213, 1993.
10. Davidson LE, Kuk JL, Church TS, Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol 100: 864-868, 2006.
11. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62: 425-435, 1978.
12. Du J, Mitch WE. Identification of pathways controlling muscle protein metabolism in uremia and other catabolic conditions. Curr Opin Nephrol Hypertens 14: 378-382, 2005.
13. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet 346: 120-121, 1995.
14. Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8: 1094-1098, 1993.
15. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39-48, 2007.
16. Goodpaster BH, Brown NF. Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise? Exerc Sport Sci Rev 33: 150-154, 2005.
17. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
18. Hager SR. Insulin resistance of uremia. Am J Kidney Dis 14: 272-276, 1989.
19. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56: 2655-2667, 2007.
20. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB Jr, Wagenknecht LE, Haffner SM. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 112: 3713-3721, 2005.
21. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 293: E1663-E1669, 2007.
22. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165: 670-676, 2002.
23. Johansen KL, Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, Kent-Braun JA. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 57: 2564-2570, 2000.
24. Johansen KL, Doyle J, Sakkas GK, Kent-Braun JA. Neural and metabolic mechanisms of excessive muscle fatigue in maintenance hemodialysis patients. Am J Physiol Regul Integr Comp Physiol 289: R805-R813, 2005.
25. Johansen KL, Shubert T, Doyle J, Soher B, Sakkas GK, Kent-Braun JA. Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. Kidney Int 63: 291-297, 2003.
26. Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 39: 297-307, 2002.
27. Kalantar-Zadeh K, Kovesdy CP, Derose SF, Horwich TB, Fonarow GC. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 3: 493-506, 2007.
28. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410, 2000.
29. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285: E906-E916, 2003.
30. Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 15: 65-70, 2000.
31. Lee S, Kuk JL, Davidson LE, Hudson R, Kilpatrick K, Graham TE, Ross R. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol 99: 1220-1225, 2005.
32. Lee SW, Park GH, Song JH, Hong KC, Kim MJ. Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant 22: 2554-2562, 2007.
33. Levinger I, Goodman C, Hare DL, Jerums G, Selig S. The effect of resistance training on functional capacity and quality of life in individuals with high and low numbers of metabolic risk factors. Diabetes Care 30: 2205-2210, 2007.
34. Lo JC, Mulligan K, Noor MA, Lee GA, Schwarz JM, Grunfeld C, Schambelan M. The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Clin Infect Dis 39: 732-735, 2004.
35. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 351: 867-870, 1998.
36. Mak RH. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial 13: 4-8, 2000.
37. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24: 539-548, 2001.
38. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470, 1999.
39. Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey DIA-QOL Group. Nephrol Dial Transplant 14: 1503-1510, 1999.
40. Miura H, Kitagami T, Ohta T. Application of the Zung self-rating depression scale to patients before and after introduction to haemodialysis. Psychiatry Clin Neurosci 53: 381-385, 1999.
41. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C. Life without white fat: a transgenic mouse. Genes Dev 12: 3168-3181, 1998.
42. Odamaki M, Furuya R, Ohkawa S, Yoneyama T, Nishikino M, Hishida A, Kumagai H. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 14: 2427-2432, 1999.
43. Painter P. Physical functioning in end-stage renal disease patients: update 2005. Hemodial Int 9: 218-235, 2005.
44. Parati G, Lombardi C, Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol 293: R1671-R1683, 2007.
45. Parker KP. Sleep disturbances in dialysis patients. Sleep Med Rev 7: 131-143, 2003.
46. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med 119: S10-S16, 2006.
47. Peterson K, Silverstein J, Kaufman F, Warren-Boulton E. Management of type 2 diabetes in youth: an update. Am Fam Physician 76: 658-664, 2007.
48. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 136: 167-178, 2003.
49. Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, Croce LS, Paoletti S, de Bernard B, Tiribelli C, Dalla Palma L. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 27: 108-113, 1997.
50. Roberts CK, Barnard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol 98: 3-30, 2005.
51. Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, Roriz-Filho JS, Cruz TR, Rodrigues RP, Resmini I, Sudoh S, Wakatsuki Y, Nakagawa M, Souza AC, Kita T, Matsubayashi K. Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 55: 374-382, 2007.
52. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112: 2660-2667, 2005.
53. Sakkas GK, Ball D, Mercer TH, Sargeant AJ, Tolfrey K, Naish PF. Atrophy of non-locomotor muscle in patients with end-stage renal failure. Nephrol Dial Transplant 18: 2074-2081, 2003.
54. Sakkas GK, Gourgoulianis KI, Karatzaferi C, Liakopoulos V, Maridaki MD, Pastaka C, Lavdas E, Soher BJ, Dovas S, Fezoulidis I, Hadjigeorgiou GM, Stefanidis I. Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. Nephrol Dial Transplant, 23: 336-344, 2008.
55. Sakkas GK, Karatzaferi C, Liakopoulos V, Maridaki MD, Lavdas E, Giannaki CD, Gourgoulianis KI, Stefanidis I. Polysomnographic evidence of sleep apnoea disorders in lean and overweight hemodialysis patients. J Ren Care 33:159-164, 2007.
56. Sakkas GK, Kent-Braun JA, Doyle JW, Shubert T, Gordon P, Johansen KL. Effect of diabetes mellitus on muscle size and strength in patients receiving dialysis therapy. Am J Kidney Dis 47: 862-869, 2006.
57. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
58. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA. Insulin resistance is associated with skeletal muscle protein break-down in non-diabetic chronic hemodialysis patients. Kidney Int 71: 146-152, 2007.
59. Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. EEG arousals: scoring rules and examples: a preliminary report. Sleep 15: 173-184, 1992.
60. Takenaka T, Kanno Y, Ohno Y, Suzuki H. Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism 56: 153-159, 2007.
61. Tsatsoulis A, Fountoulakis S. The protective role of exercise on stress system dysregulation and comorbidities. Ann NY Acad Sci 1083: 196-213, 2006.
62. Tsintzas K, Jewell K, Kamran M, Laithwaite D, Boonsong T, Littlewood J, Macdonald I, Bennett A. Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans. J Physiol 575: 291-303, 2006.
63. Zanetti M, Barazzoni R, Guarnieri G. Inflammation and insulin resistance in uremia. J Ren Nutr 18: 70-75, 2008.